Growth Metrics

Ginkgo Bioworks Holdings (DNA) Cash from Investing Activities: 2020-2025

Historic Cash from Investing Activities for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to -$72.8 million.

  • Ginkgo Bioworks Holdings' Cash from Investing Activities fell 613.88% to -$72.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$348.5 million, marking a year-over-year decrease of 263.66%. This contributed to the annual value of -$62.2 million for FY2024, which is 22.87% up from last year.
  • Ginkgo Bioworks Holdings' Cash from Investing Activities amounted to -$72.8 million in Q3 2025, which was down 13.97% from -$63.9 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Cash from Investing Activities ranged from a high of $29.7 million in Q4 2022 and a low of -$198.7 million during Q1 2025.
  • Its 3-year average for Cash from Investing Activities is -$43.5 million, with a median of -$19.4 million in 2023.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Cash from Investing Activities surged by 603.41% in 2022, and later plummeted by 1,540.66% in 2025.
  • Quarterly analysis of 5 years shows Ginkgo Bioworks Holdings' Cash from Investing Activities stood at $4.2 million in 2021, then skyrocketed by 603.41% to $29.7 million in 2022, then slumped by 256.94% to -$46.7 million in 2023, then spiked by 71.97% to -$13.1 million in 2024, then crashed by 613.88% to -$72.8 million in 2025.
  • Its Cash from Investing Activities was -$72.8 million in Q3 2025, compared to -$63.9 million in Q2 2025 and -$198.7 million in Q1 2025.